Unspecified B-cell lymphoma affecting the intrapelvic lymph nodes is a type of non-Hodgkin lymphoma characterized by the proliferation of B-lymphocytes. This condition is clinically significant due to its potential for aggressive behavior and varied presentation. Accurate coding with ICD-10 Code C85.16 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this malignancy.
ICD-10 Code C85.16 represents Unspecified B-cell lymphoma localized in the intrapelvic lymph nodes. This code is utilized when the specific subtype of B-cell lymphoma is not identified, yet the presence of lymphoma in the intrapelvic lymph nodes is confirmed. It is crucial for clinical documentation and billing, particularly when managing patients with lymphoproliferative disorders.
Unspecified B-cell lymphoma in the intrapelvic lymph nodes arises from malignant transformation of B-lymphocytes, leading to lymphadenopathy and potential systemic symptoms. The condition may progress rapidly, necessitating prompt medical evaluation and intervention.
ICD-10 Code C85.16 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It aids in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code C85.16 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of lymphoma. This code is vital for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.
The management of Unspecified B-cell lymphoma in the intrapelvic lymph nodes often requires hospitalization for intensive treatment. Chemotherapy is the primary treatment modality, and supportive care is essential.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C85.16 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance |
| 96415 | Chemotherapy administration, intravenous, each additional substance |
| 99214 | Established patient office visit, moderate complexity |
| 85025 | Complete blood count with automated differential white blood cell count |
Common Questions About Using ICD-10 Code C85.16 for Unspecified B-cell lymphoma, intrapelvic lymph nodes
What are the common symptoms of Unspecified B-cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, night sweats, and fatigue. Patients may also experience pain in the affected areas, particularly if lymph nodes are enlarged.
How is Unspecified B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of the affected lymph nodes. Laboratory tests may also be conducted to assess blood counts and other markers.
What treatment options are available for this condition?
Treatment often includes chemotherapy, radiation therapy, and in some cases, stem cell transplantation. Supportive care is also important to manage symptoms and side effects.
Is hospitalization required for patients with this diagnosis?
Hospitalization may be necessary for patients undergoing intensive chemotherapy or experiencing complications. Close monitoring is essential during treatment to manage potential side effects.
Clinical Notes
SOAP notes
DAP notes
AI medical notes